Rui Qin

1.2k total citations
36 papers, 883 citations indexed

About

Rui Qin is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Rui Qin has authored 36 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Rui Qin's work include Statistical Methods in Clinical Trials (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Optimal Experimental Design Methods (3 papers). Rui Qin is often cited by papers focused on Statistical Methods in Clinical Trials (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Optimal Experimental Design Methods (3 papers). Rui Qin collaborates with scholars based in United States, China and France. Rui Qin's co-authors include Yi Lin, Carol L. Szumlanski, Allan B. Dietz, Xinghua Zhao, Peggy A. Bulur, Stanimir Vuk‐Pavlović, Sumithra J. Mandrekar, Daniel J. Sargent, Chen Zhao and John C. Morris and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Neurology.

In The Last Decade

Rui Qin

33 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Qin United States 17 336 280 266 191 87 36 883
Sophie Glatt United Kingdom 10 189 0.6× 142 0.5× 365 1.4× 35 0.2× 34 0.4× 14 858
Marshall S. Scicchitano United States 16 555 1.7× 175 0.6× 89 0.3× 248 1.3× 70 0.8× 24 1.1k
Ke Wu China 19 395 1.2× 72 0.3× 212 0.8× 172 0.9× 36 0.4× 72 1.0k
Krithika Bhuvaneshwar United States 14 350 1.0× 110 0.4× 79 0.3× 182 1.0× 88 1.0× 32 624
Charles Paulding United States 9 583 1.7× 200 0.7× 76 0.3× 85 0.4× 96 1.1× 15 1.1k
Abhik Mukherjee United Kingdom 17 386 1.1× 309 1.1× 108 0.4× 210 1.1× 83 1.0× 41 776
Changjie Wu China 14 473 1.4× 177 0.6× 49 0.2× 219 1.1× 68 0.8× 24 706
Lisa Iacono United States 14 320 1.0× 278 1.0× 23 0.1× 67 0.4× 200 2.3× 34 761
Xiaowen Zhou China 13 258 0.8× 145 0.5× 117 0.4× 53 0.3× 62 0.7× 51 607
T Kobayashi Japan 16 392 1.2× 116 0.4× 186 0.7× 125 0.7× 84 1.0× 46 793

Countries citing papers authored by Rui Qin

Since Specialization
Citations

This map shows the geographic impact of Rui Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Qin more than expected).

Fields of papers citing papers by Rui Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Qin. The network helps show where Rui Qin may publish in the future.

Co-authorship network of co-authors of Rui Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Qin. A scholar is included among the top collaborators of Rui Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Qin. Rui Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Rui, et al.. (2025). Long-term tracking of urban structure and analysis of its impact on urban heat stress: a case study of Xi’an, China. Ecological Indicators. 174. 113418–113418. 13 indexed citations
2.
Heald, Adrian, Rui Qin, Camila Marcelino Loureiro, et al.. (2023). A study to investigate genetic factors associated with weight gain in people with diabetes: analysis of polymorphisms in four relevant genes. Adipocyte. 12(1). 2236757–2236757.
3.
Wan, Jiawei, Xiujuan Yu, Jiao Liu, et al.. (2023). A special polysaccharide hydrogel coated onBrasenia schreberi: preventive effects against ulcerative colitisviamodulation of gut microbiota. Food & Function. 14(8). 3564–3575. 13 indexed citations
4.
Qin, Rui, et al.. (2022). Catalpol Ameliorates Oxidative Stress and Neuroinflammation after Traumatic Brain Injury in Rats. Neurochemical Research. 48(2). 681–695. 11 indexed citations
5.
Zhan, Peng, et al.. (2022). [Identification of Carthamus tinctorius NAC gene family and analysis of drought stress response].. PubMed. 47(20). 5520–5529. 3 indexed citations
6.
Yin, Jun, et al.. (2021). phase1RMD: An R package for repeated measures dose-finding designs with novel toxicity and efficacy endpoints. PLoS ONE. 16(9). e0256391–e0256391. 2 indexed citations
7.
Hubbard, Joleen M., Jun Yin, Erin L. Schenk, et al.. (2021). Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies. Investigational New Drugs. 40(1). 115–123. 2 indexed citations
8.
Qin, Rui, Wei Wang, Zhou Huang, et al.. (2019). Relationship between SNP rs1764391 and Susceptibility, Risk Factors, Gene-environment Interactions of Acute Myocardial Infarction in Guangxi Han Chinese Population. Current Pharmaceutical Biotechnology. 21(1). 79–88. 4 indexed citations
9.
Chen, Li, et al.. (2019). Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer. World Journal of Gastroenterology. 25(15). 1828–1839. 23 indexed citations
10.
Wan, Xuechao, Yufeng Zhang, Fangqiu Fu, et al.. (2018). SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis. The International Journal of Biochemistry & Cell Biology. 102. 138–150. 40 indexed citations
11.
Kulkarni, Amit, Rahul Kanwar, Peter Beyerlein, et al.. (2015). Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance). Journal of the Neurological Sciences. 357(1-2). 35–40. 39 indexed citations
12.
Chen, Li, Yan Shi, Jing Yuan, et al.. (2014). HIF-1 Alpha Overexpression Correlates with Poor Overall Survival and Disease-Free Survival in Gastric Cancer Patients Post-Gastrectomy. PLoS ONE. 9(3). e90678–e90678. 56 indexed citations
13.
Schenk, Erin L., Andrea E. Wahner Hendrickson, Donald W. Northfelt, et al.. (2013). Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies. Investigational New Drugs. 31(5). 1251–1256. 14 indexed citations
14.
Trujillo, María A., Michael O’Neal, Sean M. McDonough, Rui Qin, & John C. Morris. (2012). A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer. Cancer Gene Therapy. 19(12). 839–844. 18 indexed citations
15.
Reid, Joel M., Chad A. Walden, Rui Qin, et al.. (2011). Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668. Cancer Prevention Research. 4(3). 347–353. 16 indexed citations
16.
Bryce, Alan H., Jann N. Sarkaria, Joel M. Reid, et al.. (2011). Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors. Investigational New Drugs. 30(5). 1934–1941. 22 indexed citations
17.
Qin, Rui, et al.. (2010). カペシタビンによる手足症候群の予防における,尿素/乳酸ベースの外用角質溶解剤の有効性を明らかにするプラセボ比較対照試験:米国の北中部癌治療グループ (NCCTG)の試験N05C5. Journal of Clinical Oncology. 28(35). 5182–5187. 1 indexed citations
18.
Mandrekar, Sumithra J., Rui Qin, & Daniel J. Sargent. (2010). Model‐based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: Methods and challenges. Statistics in Medicine. 29(10). 1077–1083. 35 indexed citations
20.
Larson, David W., William J. Sandborn, Edward V. Loftus, et al.. (2010). Recurrence and Impact of Postoperative Prophylaxis in Laparoscopically Treated Primary Ileocolic Crohn Disease. Archives of Surgery. 145(1). 42–7. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026